Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Andrea Adamus"'
Autor:
Lesley Ann Miller, Luisa Franzini, Lincy S. Lal, Rebecca Arbuckle, Stacey Dacosta Byfield, Chun Feng, John M. Swint, Liezl Reasonda, Andrea Adamus, Eric L. Chang
Publikováno v:
American journal of clinical oncology. 35(1)
Background In this study, we compare 2 treatment options and determine cost-effectiveness and cost-utility. Methods We carried out a decision analysis populated with data from patients with brain metastasis in a concurrent trial randomized to either
Autor:
Lincy S, Lal, Lesley-Ann N, Miller, Rebecca, Arbuckle, Frank, Hung, Chun, Feng, Andrea, Adamus, Michael J, Fisch
Publikováno v:
The journal of supportive oncology. 7(6)
Our objective was to assess the prevalence of use of different classes of antidepressants, prescribing patterns, and determinants of exposure to specific types of antidepressants and resource utilization at a comprehensive cancer center from 2001 to
Autor:
Rebecca Arbuckle, Andrea Adamus, Amy Zhuang, Stacey Dacosta Byfield, Chun Feng, Lincy S. Lal, LA Miller, Frank Hung
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 17(2)
Objective. The purpose is to evaluate antidepressant compliance in a cancer population at a tertiary cancer center and to determine if there are covariates of importance in predicting the level of compliance in the study population. Methods. Patients
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 2(3)
Healthcare costs in the USA continue to rise faster than the consumer price index. Nothing demonstrates this more vividly than the double-digit increases posted for the cost of the drug treatment of the oncology patient. A factor that will compound t
Autor:
Ana O. Hoff, Valentina Guarneri, Kimberly Desrouleaux, Kadri Altundag, Mimi Hu, Carla L. Warneke, Jeffrey Cui, Andrea Adamus, Gabriel N. Hortobagyi, Marcella M. Johnson, Ajay K. Nooka, Gilbert Sayegh, Robert F. Gagel, Bela B. Toth
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 23(6)
Introduction: Osteonecrosis of the jaw (ONJ) has been reported in patients treated with bisphosphonates. The incidence and risk factors associated with this disorder have not been clearly defined. Materials and Methods: We conducted a retrospective a
Autor:
Jeffrey T. Sherer, Andrea Adamus
Publikováno v:
Pharmacotherapy. 27(2)
Study Objective. To determine the relative effectiveness of two bisphosphonates—pamidronate and zoledronic acid—for preventing skeletal-related events (SREs) in patients with prostate cancer metastatic to bone. Design. Retrospective cohort study.
Autor:
Robert F. Gagel, Bela B. Toth, Ajay K. Nooka, Valentina Guarneri, Gabriel N. Hortobagyi, Andrea Adamus, Gilbert Sayegh, Ana O. Hoff, Kadri Altundag, Marcy M. Johnson
Publikováno v:
Journal of Clinical Oncology. 24:8528-8528
8528 There have been reports of osteonecrosis of the jaw (ONJ) in patients (pts) with metastatic bone disease (MBD) treated with IV bisphosphonates (IVBP). To estimate the frequency and identify risk factors for ONJ we performed a retrospective analy
Publikováno v:
International Journal of Radiation OncologyBiologyPhysics. 60:S406-S406
Materials/Methods: A time trade-off instrument was developed to directly elicit preferences from patients on the trial. The elicitation instrument included a written script, data collection form, and visual aid to facilitate the understanding of trad